Skip to content
The Nexus
DossierENTITY

Biomedical Advanced Research and Development Authority

Coverage of Biomedical Advanced Research and Development Authority in the Nexus archive.

Earliest in view: Jun 4 · 23:40 UTCMost recent: Jun 4 · 23:40 UTC
Co-mentioned in this coverage
Department of Health and Human Servicesorganization1Mapp Biopharmaceuticalsorganization1MBP-134topic1Ebolatopic1Central Africaplace1
Recent coverage
  • HEALTHJun 4 · 23:40 UTCSTAT NEWS
    HHS confirms Americans with high-risk Ebola exposures will have access to experimental therapy

    HHS confirms Americans with high-risk Ebola exposures in Central Africa will receive access to an experimental antibody treatment, MBP-134, developed by Mapp Biopharmaceuticals with funding from the Biomedical Advanced Research and Development Authority. The treatment has shown promise in animal testing but has not yet been clinically proven effective in humans.

Biomedical Advanced Research and Development Authority · Dossier · The Nexus